Kanubaddi Avani 4
4 · Enveric Biosciences, Inc. · Filed Jan 25, 2022
Insider Transaction Report
Form 4
Kanubaddi Avani
Chief Operating Officer
Transactions
- Award
Restricted Stock Units
2022-01-19+1,127,787→ 1,127,787 total→ Common Stock (1,127,787 underlying)
Footnotes (2)
- [F1]Represents the restricted stock units (the "RSUs") granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the "Company") 2020 Long-Term Incentive Plan. For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock.
- [F2]50% of the RSUs shall vest over 4 years in equal annual installments, with the first tranche to vest on January 19, 2023. 50% of the RSUs shall vest in 3 approximately equal tranches on each of December 31, 2022, 2023 and 2024, if the Company's average VWAP (calculated as the average over the fourth calendar quarter of each of 2022, 2023 and 2024, as applicable, of the daily volume weighted average price of a share of common stock), exceeds $1.72, $1.89, $2.08, respectively.